Medicines will continue to rise

Due to the crisis, the Russian pharmaceutical market grew in a ruble dimension compared to the first quarter of last year by a third according to the DSM Group industry analytical agency, in the first quarter of 2009, compared to the same period in 2008, the commercial market for drugs grew by 31% in ruble expression.

Analysts explain such an increase in the market primarily by increasing prices. The drug prices for three months of this year in relation to December 2008 amounted to 12.4%. As a result, the volume of the commercial market (in consumer prices with VAT) in the first quarter of 2009 amounted to 72.5 billion rubles (or $ 2.1 billion), and in dollar terms the market decreased by 7.6%.

“According to our forecasts,” says Alexander Kuzin, Director General of DSM Group, “the market volume of the market this year will increase by about a quarter in ruble terms, and its main driving factor will remain the price of prices.” By the rating of the agency on the farm market in the first quarter, the Farmstandart company is the leader, in second place - Sanofi -Aventis, in third place - Berlin -chemie (A. Menarini). Gedeon Richter (+44%), Nycomed (+41%) and KRKA (+41%) grow by the greatest pace by last year.

The average cost of packaging drugs in the commercial market of Russia for the first quarter increased by 31% compared to the same period last year and amounted to 72.5 rubles. In dollar terms, the price fell 7% to $ 2.11. The most popular drug in the pharmacies of Russia in the first quarter was Arbidol, in second place - Oscillococcinum, in the third - Actovegin.

04/21/2009 / Irina Vlasova